Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
PTPRK Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PTPRK sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PTPRF Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PTPRF sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PTH1R Biologics Sequence Review Report 2026: Parathyroid hormone/parathyroid hormone-related peptide receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PTH1R sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PRTN3 Biologics Sequence Review Report 2026: Myeloblastin Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PRTN3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PROS1 Biologics Sequence Review Report 2026: Vitamin K-dependent protein S Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PROS1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PROKR2 Biologics Sequence Review Report 2026: Prokineticin receptor 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PROKR2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PROKR1 Biologics Sequence Review Report 2026: Prokineticin receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PROKR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PROCR Biologics Sequence Review Report 2026: Endothelial protein C receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PROCR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PLXND1 Biologics Sequence Review Report 2026: Plexin-D1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXND1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PLXNC1 Biologics Sequence Review Report 2026: Plexin-C1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNC1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PLXNB3 Biologics Sequence Review Report 2026: Plexin-B3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNB3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PLXNB2 Biologics Sequence Review Report 2026: Plexin-B2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNB2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.